Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$13,319,305
+$1,369,752 QoQ
Shares Held
52,930
-3.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#236
of 1,872 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $69,954,680 across 17 Drug Manufacturers - General names. ABBV ranks #2 (19.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,352 | $24,410,801 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
52,930 | $13,319,305 | |
| 3 | JNJ |
Johnson & Johnson
|
38,760 | $9,843,877 | |
| 4 | PFE |
Pfizer Inc
|
228,411 | $5,500,136 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,895 | $3,970,007 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
57,120 | $3,291,254 | |
| 7 | AMGN |
Amgen Inc
|
8,216 | $2,975,177 | |
| 8 | NVO |
Novo Nordisk A S
|
30,253 | $1,450,328 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,319,305 | 52,930 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $11,949,553 | 54,943 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $9,885,848 | 43,266 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $10,042,815 | 43,374 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $7,997,808 | 43,087 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $8,782,240 | 41,916 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $7,685,347 | 43,249 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $7,567,631 | 38,321 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $5,498,416 | 32,057 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $5,446,611 | 29,910 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $4,829,020 | 31,161 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $7,159,351 | 48,030 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $6,296,067 | 46,731 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,428,873 | 46,614 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $10,811,224 | 66,897 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $9,045,082 | 67,395 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $9,374,464 | 61,207 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $9,922,266 | 61,207 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $5,887,598 | 43,483 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $4,834,517 | 44,818 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $4,392,734 | 38,998 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $3,964,098 | 36,630 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $3,955,870 | 36,919 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $3,007,577 | 34,337 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $2,943,927 | 29,985 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,903,454 | 24,983 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||